For its report, analysts at Wells Fargo reviewed PriceRx data from August.
Here are four report findings:
1. The cost of 48 drugs went down in August. In July, 32 drug prices were lowered.
2. The 60 price hikes ranged from 486 percent to 1.6 percent, with a median increase of 9.9 percent.
3. The 48 drug price decreases ranged from 1.5 percent to 88 percent, with a median decrease of 38.6 percent.
4. Seven drugs increased in price by 100 percent or more. Those drugs included: FLUoxetine, Nitrofurantoin, Irbesartan-Hydrochlorothiazide, Valsartan, Thiamine, DilTIAZem and Ondansetron. Many of these drugs are generics.
More articles on pharmacy:
Hospitals mark up drugs by 479%: 6 report findings
6 latest drug, medical device recalls
US-Mexico trade deal grants drugmakers 10 years of patent exclusivity on biologics
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
